Genetic Analysis Genetics Protein Research 
Drug Discovery World
MARCH 2, 2023
AVA6000 is a pre|CISION tumour-targeted form of the established chemotherapy doxorubicin; designed to limit cell penetration of the drug — and therefore its cell killing effect — until it is specifically activated by fibroblast activation protein α (FAP), which is in high concentration in many solid tumours compared with healthy tissues.
Drug Discovery World
DECEMBER 14, 2023
Early operations focused on the discovery of green fluorescent protein (GFP), which played a very big role in early drug discovery research operations using cellular assays. But it comes with surface charge that will absorb proteins, DNA, and other things, unless you do something to treat that surface.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
FEBRUARY 28, 2023
As we turn our focus to new potential applications and disease areas for the platform, scientists and companies must consider the potential life-saving impact on rare, inherited diseases, says Archana Gupta , PhD, staff scientist in genetic sciences at Thermo Fisher Scientific.
pharmaphorum
APRIL 5, 2022
Researchers at the Institute of Cancer Research (ICR) in London have designed a prototype test that they think could be used to predict which combinations are likely to work in cancer patients within two days. The researchers are already planning a larger follow-up study which will test 15 drugs and look at 12,000 tumour cell proteins.
XTalks
MARCH 7, 2024
Other issues include medical systems that can often be dismissive of women’s health concerns or experiences, and historically less research on women’s health, which together, can lead to late diagnoses or misdiagnoses. Through this, researchers can pinpoint breast cancer cell types and their phenotypic states.
XTalks
DECEMBER 15, 2020
Plant proteins , milk alternatives , meat alternatives , bee-less honey , lab-grown meat and more are all kinds of innovations we have seen in 2020, but studies show that plant-based trends are still on the rise as new technologies are developed to cater to this market. I did my research and found that it didn’t exist.
Drug Discovery World
APRIL 21, 2023
Atrandi Biosciences’ novel technology platform enables researchers to gain insights into the biology of single cells, offering immediate applications in single-cell sequencing, drug and antibody discovery, functional metagenomics, microbial analysis, directed evolution, and synthetic biology. It will be led by Björn C.
Expert insights. Personalized for you.
52 
Let's personalize your content